Lung cancer is worldwide the most common form of cancer and the most common cause of death from cancer. It accounts for approximately 28% of all cancer deaths. World-wide 1.2 million people die from lung cancer each year. In the Netherlands, 9,918 people died from lung cancer in 2008. Lung cancer is often diagnosed in an advanced incurable stage. Despites advances in treatment, 85% or more patients will die within 5 years after diagnosis. In the Netherlands, the mortality-incidence ratio is 95%. Total costs of lung cancer in the Netherlands were estimated to be 193 million euro in 2005.

lung cancer, quality of life, screening
H.J. de Koning (Harry)
Erasmus University Rotterdam
Netherlands Organisation of Health Research and Development (ZonMw), Dutch Cancer Society (KWF), Health Insurance Innovation Foundation (Innovatiefonds Zorgverzekeraars)
978-90-8559-075-0
hdl.handle.net/1765/20931
Erasmus MC: University Medical Center Rotterdam

van den Bergh, K. (2010, October 13). Health-related Quality of Life and Informed Decision-making in Lung Cancer Screening. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/20931